Skip to main content
Top
Published in: BMC Ophthalmology 1/2020

Open Access 01-12-2020 | Glaucoma | Research article

Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients

Authors: Mengyu Liao, Xiaohong Wang, Jinguo Yu, Xiangda Meng, Yuanyuan Liu, Xue Dong, Jianan Li, Rodrigo Brant, Bo Huang, Hua Yan

Published in: BMC Ophthalmology | Issue 1/2020

Login to get access

Abstract

Background

Proliferative diabetic retinopathy (PDR) is one of the most common cause of vision loss in diabetic patients, and the incidence age of PDR patients gradually gets younger. This study aims to compare the characteristics of PDR and outcomes following vitrectomy in young and senior patients.

Methods

This is a retrospective case series study. Data of 116 eyes of 92 patients who underwent vitrectomy for PDR from February 2012 to February 2017 were reviewed, which were divided into young and senior patient groups. All patients were followed up for 24 months at least.

Results

There were 62.1% of eyes with tractional retinal detachment secondary to PDR in the young patient group, while only 12.1% of eyes in the senior patient group with this surgery indication. (P < 0.001) The best corrected visual acuity increased in 41 eyes (70.7%), stable in 9 eyes (15.5%), and decreased in 8 eyes (13.8%) in young patients at the final follow-up. And it increased in 47 eyes (81.0%), stable in 2 eyes (3.4%), and decreased in 9 eyes (15.5%) in senior patients.(P = 0.085) Postoperative complications mainly included recurrent vitreous hemorrhage (24.1%), retinal detachment (3.4%), neovascular glaucoma (NVG) (27.6%) and nuclear sclerosis (53.4%) in young patients, and it was 19.0, 0.0, 1.7 and 3.4% in senior patients respectively.

Conclusion

PDR of young patients is more severe than that of senior patients, and vitrectomy is an effective and safe method for PDR treatment. NVG is a main and severe complication besides nuclear sclerosis in young patients, and the incidence of NVG is higher compared to that in senior patients.
Literature
1.
go back to reference Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124–36.CrossRef Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124–36.CrossRef
2.
go back to reference Wenying Y, Juming L, Jianping W, Weiping J, Linong J, Jianzhong X, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(25):1090–101. Wenying Y, Juming L, Jianping W, Weiping J, Linong J, Jianzhong X, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(25):1090–101.
3.
go back to reference Zhang G, Chen H, Chen W, Zhang M. Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study. Br J Ophthalmol. 2017;101(12):1591–5. Zhang G, Chen H, Chen W, Zhang M. Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study. Br J Ophthalmol. 2017;101(12):1591–5.
4.
go back to reference Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye (Lond). 2004;18(10):963–83.CrossRef Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye (Lond). 2004;18(10):963–83.CrossRef
5.
go back to reference Newman DK. Surgical management of the late complications of proliferative diabetic retinopathy. Eye (Lond). 2010;24(3):441–9.CrossRef Newman DK. Surgical management of the late complications of proliferative diabetic retinopathy. Eye (Lond). 2010;24(3):441–9.CrossRef
6.
go back to reference Qamar RM, Saleem MI, Saleem MF. The outcomes of pars plana vitrectomy without endotamponade for tractional retinal detachment secondary to proliferative diabetic retinopathy. Int J Ophthalmol. 2013;6(5):671–4.PubMedPubMedCentral Qamar RM, Saleem MI, Saleem MF. The outcomes of pars plana vitrectomy without endotamponade for tractional retinal detachment secondary to proliferative diabetic retinopathy. Int J Ophthalmol. 2013;6(5):671–4.PubMedPubMedCentral
7.
go back to reference Arevalo JF, Maia M, Flynn HW Jr, Saravia M, Avery RL, Wu L, et al. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol. 2011;92(2):213–6.CrossRef Arevalo JF, Maia M, Flynn HW Jr, Saravia M, Avery RL, Wu L, et al. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol. 2011;92(2):213–6.CrossRef
8.
go back to reference Susanne S, Katharina K, Andreas W. Incidence of rhegmatogenous retinal detachment after vitrectomy in eyes of diabetic patients. Retina. 2006;26(2):149.CrossRef Susanne S, Katharina K, Andreas W. Incidence of rhegmatogenous retinal detachment after vitrectomy in eyes of diabetic patients. Retina. 2006;26(2):149.CrossRef
9.
go back to reference Kwon JW, Jee D, La TY. Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy. Medicine (Baltimore). 2017;96(10):e6263.CrossRef Kwon JW, Jee D, La TY. Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy. Medicine (Baltimore). 2017;96(10):e6263.CrossRef
10.
go back to reference Liao N, Li C, Jiang H, Fang A, Zhou S, Wang Q. Neovascular glaucoma: a retrospective review from a tertiary center in China. BMC Ophthalmol. 2016;16(1):14.CrossRef Liao N, Li C, Jiang H, Fang A, Zhou S, Wang Q. Neovascular glaucoma: a retrospective review from a tertiary center in China. BMC Ophthalmol. 2016;16(1):14.CrossRef
11.
go back to reference Yan H, Cui J, Lu Y, Yu J, Chen S, Xu Y. Reasons for and Management of Postvitrectomy Vitreous Hemorrhage in proliferative diabetic retinopathy. Curr Eye Res. 2010;35(4):308–13.CrossRef Yan H, Cui J, Lu Y, Yu J, Chen S, Xu Y. Reasons for and Management of Postvitrectomy Vitreous Hemorrhage in proliferative diabetic retinopathy. Curr Eye Res. 2010;35(4):308–13.CrossRef
12.
go back to reference Sato T, Tsuboi K, Nakashima H, Emi K. Characteristics of cases with postoperative vitreous hemorrhage after 25-gauge vitrectomy for repair of proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2016;255(4):1–7. Sato T, Tsuboi K, Nakashima H, Emi K. Characteristics of cases with postoperative vitreous hemorrhage after 25-gauge vitrectomy for repair of proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2016;255(4):1–7.
13.
go back to reference Liang X, Zhang Y, Wang J, Wang L, Huang W, Tang X. Intravitreal ranibizumab injection at the end of vitrectomy for diabetic vitreous hemorrhage (observational study). Medicine (Baltimore). 2019;98(20):e15735.CrossRef Liang X, Zhang Y, Wang J, Wang L, Huang W, Tang X. Intravitreal ranibizumab injection at the end of vitrectomy for diabetic vitreous hemorrhage (observational study). Medicine (Baltimore). 2019;98(20):e15735.CrossRef
14.
go back to reference Yokoyama H, Okudaira M, Otani T, Takaike H, Miura J, Saeki A, Uchigata Y, et al. Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications. Diabetes Care. 1997;20(5):844–7.CrossRef Yokoyama H, Okudaira M, Otani T, Takaike H, Miura J, Saeki A, Uchigata Y, et al. Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications. Diabetes Care. 1997;20(5):844–7.CrossRef
15.
go back to reference Huang CH, Hsieh YT, Yang CM. Vitrectomy for complications of proliferative diabetic retinopathy in young patients: clinical features and surgical outcomes. Graefes Arch Clin Exp Ophthalmol. 2017;255(5):863–71.CrossRef Huang CH, Hsieh YT, Yang CM. Vitrectomy for complications of proliferative diabetic retinopathy in young patients: clinical features and surgical outcomes. Graefes Arch Clin Exp Ophthalmol. 2017;255(5):863–71.CrossRef
16.
go back to reference Wong J, Molyneaux L, Constantino M, Twigg SM, Yue DK. Timing is everything: age of onset influences long-term retinopathy risk in type 2 diabetes, independent of traditional risk factors. Diabetes Care. 2008;31(10):1985–90.CrossRef Wong J, Molyneaux L, Constantino M, Twigg SM, Yue DK. Timing is everything: age of onset influences long-term retinopathy risk in type 2 diabetes, independent of traditional risk factors. Diabetes Care. 2008;31(10):1985–90.CrossRef
17.
go back to reference Rajalakshmi R, Amutha A, Ranjani H, Ali MK, Unnikrishnan R, Anjana RM, et al. Prevalence and risk factors for diabetic retinopathy in Asian Indians with young onset type 1 and type 2 diabetes. J Diabetes Complicat. 2014;28(3):291–7.CrossRef Rajalakshmi R, Amutha A, Ranjani H, Ali MK, Unnikrishnan R, Anjana RM, et al. Prevalence and risk factors for diabetic retinopathy in Asian Indians with young onset type 1 and type 2 diabetes. J Diabetes Complicat. 2014;28(3):291–7.CrossRef
18.
go back to reference Pinhas-Hamiel O, Zeitler P. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet. 2007;369(9575):1823–31.CrossRef Pinhas-Hamiel O, Zeitler P. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet. 2007;369(9575):1823–31.CrossRef
19.
go back to reference Zoungas S, Woodward M, Li Q, Cooper ME, Hamet P, Harrap S, et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 2014;57(12):2465–74.CrossRef Zoungas S, Woodward M, Li Q, Cooper ME, Hamet P, Harrap S, et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 2014;57(12):2465–74.CrossRef
20.
go back to reference Do DV, Wang X, Vedula SS, Marrone M, Sleilati G, Hawkins BS, Frank RN. Blood pressure control for diabetic retinopathy. Cochrane Database Syst Rev. 2015;1:CD006127.PubMedPubMedCentral Do DV, Wang X, Vedula SS, Marrone M, Sleilati G, Hawkins BS, Frank RN. Blood pressure control for diabetic retinopathy. Cochrane Database Syst Rev. 2015;1:CD006127.PubMedPubMedCentral
21.
go back to reference Kostraba JN, Klein R, Dorman JS, Dorothy JB, Drash AL, Maser RE, Ochard TJ. The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy. Am J Epidemiol. 1991;133(4):381–91.CrossRef Kostraba JN, Klein R, Dorman JS, Dorothy JB, Drash AL, Maser RE, Ochard TJ. The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy. Am J Epidemiol. 1991;133(4):381–91.CrossRef
22.
go back to reference Zhou YJ, You CY, Wang T, Zhang MX, Song YT, Liao MY, et al. Anastalsis of triamcinolone acetonide during vitrectomy in proliferative diabetic retinopathy. Chin J Exp Ophthalmol. 2017;35(5):439–42. Zhou YJ, You CY, Wang T, Zhang MX, Song YT, Liao MY, et al. Anastalsis of triamcinolone acetonide during vitrectomy in proliferative diabetic retinopathy. Chin J Exp Ophthalmol. 2017;35(5):439–42.
23.
go back to reference Bishop PN, Holmes DF, Kadler KE, McLeod D, Bos KJ. Age-related changes on the surface of vitreous collagen fibrils. Invest Ophthalmol Vis Sci. 2004;45(4):1041.CrossRef Bishop PN, Holmes DF, Kadler KE, McLeod D, Bos KJ. Age-related changes on the surface of vitreous collagen fibrils. Invest Ophthalmol Vis Sci. 2004;45(4):1041.CrossRef
24.
go back to reference Sebag J. Posterior Vitreous Detachment. Ophthalmology. 2018;125(9):1384–5.CrossRef Sebag J. Posterior Vitreous Detachment. Ophthalmology. 2018;125(9):1384–5.CrossRef
25.
go back to reference Gella L, Raman R, Kulothungan V, Sharma T. Prevalence of posterior vitreous detachment in the population with type II diabetes mellitus and its effect on diabetic retinopathy: Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetic study SN-DREAMS report no. 23. Jpn J Ophthalmol. 2012;56(3):262–7.CrossRef Gella L, Raman R, Kulothungan V, Sharma T. Prevalence of posterior vitreous detachment in the population with type II diabetes mellitus and its effect on diabetic retinopathy: Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetic study SN-DREAMS report no. 23. Jpn J Ophthalmol. 2012;56(3):262–7.CrossRef
26.
go back to reference Osaadon P, Fagan XJ, Lifshitz T, Levy J. A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye (Lond). 2014;28(5):510–20. Osaadon P, Fagan XJ, Lifshitz T, Levy J. A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye (Lond). 2014;28(5):510–20.
27.
go back to reference Sakamoto M, Hashimoto R, Yoshida I, Ubuka M, Maeno T. Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy. Clin Ophthalmol. 2018;12:2323–9.CrossRef Sakamoto M, Hashimoto R, Yoshida I, Ubuka M, Maeno T. Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy. Clin Ophthalmol. 2018;12:2323–9.CrossRef
28.
go back to reference Psichias A, Bartz-Schmidt KU, Thumann G, Krieglstein GK, Heimann K. Vitreoretinal surgery in the treatment of neovascular glaucoma. Klin Monbl Augenheilkd. 1999;214(2):61–70.CrossRef Psichias A, Bartz-Schmidt KU, Thumann G, Krieglstein GK, Heimann K. Vitreoretinal surgery in the treatment of neovascular glaucoma. Klin Monbl Augenheilkd. 1999;214(2):61–70.CrossRef
29.
go back to reference Hua Y. Outcomes of 23-gauge Vitrectomy combined with phacoemulsification, Panretinal photocoagulation, and trabeculectomy without use of anti-VEGF agents for Neovascular Glaucoma with vitreous hemorrhage. J Ophthalmol. 2016;2016:1–7.CrossRef Hua Y. Outcomes of 23-gauge Vitrectomy combined with phacoemulsification, Panretinal photocoagulation, and trabeculectomy without use of anti-VEGF agents for Neovascular Glaucoma with vitreous hemorrhage. J Ophthalmol. 2016;2016:1–7.CrossRef
30.
go back to reference Steel DH. Cataract surgery after diabetic vitrectomy. Acta Ophthalmol. 2015;93(2):e168.CrossRef Steel DH. Cataract surgery after diabetic vitrectomy. Acta Ophthalmol. 2015;93(2):e168.CrossRef
31.
go back to reference Memon AF, Mahar PS, Memon MS, Mumtaz SN, Shaikh SA, Fahim MF. Age-related cataract and its types in patients with and without type 2 diabetes mellitus: a hospital-based comparative study. J Pak Med Assoc. 2016;66(10):1272–6.PubMed Memon AF, Mahar PS, Memon MS, Mumtaz SN, Shaikh SA, Fahim MF. Age-related cataract and its types in patients with and without type 2 diabetes mellitus: a hospital-based comparative study. J Pak Med Assoc. 2016;66(10):1272–6.PubMed
Metadata
Title
Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients
Authors
Mengyu Liao
Xiaohong Wang
Jinguo Yu
Xiangda Meng
Yuanyuan Liu
Xue Dong
Jianan Li
Rodrigo Brant
Bo Huang
Hua Yan
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2020
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-020-01688-3

Other articles of this Issue 1/2020

BMC Ophthalmology 1/2020 Go to the issue